Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug

Journal of Rheumatology

Volumn 26, Issue 2, 1999, Pages 259-261

  Rich, Eric ^a,b   Moreland, Larry W ^a   Alarcón, Graciela S ^a  

^a MEB 625   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Disease Progression; Methotrexate; Radiographs; Rheumatoid Arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; METHOTREXATE; RHEUMATOID FACTOR;

ADULT; ARTICLE; BONE EROSION; CLINICAL ARTICLE; DISEASE COURSE; DRUG EFFECT; FEMALE; HAND RADIOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; WRIST RADIOGRAPHY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0032901316     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kremer JM. Historical overview of the treatment of rheumatoid arthritis with an emphasis on methotrexate. J Rheumatol 1996;23:34-7.
2. Sandoval DM, Alarcón GS. Adverse events in methotrexate-treated rheumatoid arthritis patients. Br J Rheumatol 1995;34:49-56.
3. Bannwarth B, Labat L, Moride Y, Schaeverbeke T. Methotrexate in rheumatoid arthritis. An update. Drugs 1994;47:25-50.
4. López-Méndez A, Daniel WW, Reading JC, Ward JR, Alarcón GS. Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the Cooperative Systemic Studies of the Rheumatic Diseases Program randomized clinical trial of methotrexate, auranofin, or a combination of the two. Arthritis Rheum 1993;36:1364-9.
5. Sany J, Kaliski S, Courel M, Cuchacovich M, Daures J. Radiologic progression during intramuscular methotrexate treatment of rheumatoid arthritis. J Rheumatol 1990;17:1636-41.
6. Nordstrom DM, West SG, Andersen PA, Sharp JT. Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study. Ann Intern Med 1987; 107:797-801.
7. Alarcón GS, López-Méndez A, Walter J, et al. Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol 1992;19:1868-73.
8. Pincus T, Callahan L. How many types of patients meet classification criteria for rheumatoid arthritis? J Rheumatol 1994;21:1385-9.
9. Hunter T. The prognosis of early rheumatoid arthritis: How early is early? J Rheumatol 1993;20:1999-2000.
10. Pincus T, Callahan LF. The "side effects" of rheumatoid arthritis: joint destruction, disability and early mortality. Br J Rheumatol 1993;32:28-37.
11. van der Heide A, Jacobs JWG, Bijlsma JWI, et al. The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized controlled trial. Ann Intern Med 1996;124:699-707.
12. Egsmose C, Lund B, Borg G, et al. Patients with rheumatoid arthritis benefit from early second line therapy: 5 year follow-up of a prospective double blind placebo controlled study. J Rheumatol 1995;22:2208-13.
13. Arnett RC. Revised criteria for the classification of rheumatoid arthritis. Bull Rheum Dis 1989;38:1-6.
14. American College of Rheumatology Ad Hoc Committee in Clinical Guidelines. Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 1996;39:723-31.
15. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996;39:713-22.
16. Moreland LW, Daniel WW, Alarcón GS. The value of the Norgaard view in the evaluation of erosive arthritis. J Rheumatol 1990;17:614-7.
17. Sharp JT, Young DY, Bluhm GB, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985;28:1326-35.
18. Fries JF, Bloch DA, Sharp JT, et al. Assessment of radiologic progression in rheumatoid arthritis. A randomized, controlled trial. Arthritis Rheum 1986;29:1-9.
19. Wolfe F, Ross K, Hawley DJ. Roberts FK, Cathey MA. The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: A study of 1141 patients. J Rheumatol 1993;20:2005-9.
20. Weyand CM, Hicok KC, Conn DL, Goronzy JJ. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992;117:801-6.
21. Alarcón GS. Predictive factors in rheumatoid arthritis. Am J Med 1998;103:19S-24S.
22. Emery P, Symmons DPM. What is early rheumatoid arthritis?: definition and diagnosis. In: Woolf AD, van Riel PLCM, editors. Bailliére's Clinical Rheumatology. London: W.B. Saunders; 1998:13-26.
23. Sherrer YS, Bloch DA, Mitchell DM, Young DY, Fries JF. The development of disability in rheumatoid arthritis. Arthritis Rheum 1986;29:494-500.